First Allied Advisory Services’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$332K Buy
1,467
+39
+3% +$8.09K 0.01% 860
2020
Q2
$249K Buy
+1,428
New +$228K 0.01% 914
2020
Q1
Sell
-1,404
Closed -$215K 1093
2019
Q4
$215K Buy
+1,404
New +$194K 0.01% 1085

Other funds holding CRL

First Allied Advisory Services's CRL Position: Q3 2020 in Review

First Allied Advisory Services increased its Charles River Laboratories (CRL) stake by 2.7% in Q3 2020, buying an estimated $8.09K and bringing the position to 1,467 shares worth $332K. The position accounts for 0.01% of the portfolio, ranked #860.

First Allied Advisory Services first reported a position in CRL in Q4 2019 and has held it in 3 quarters since. 491 funds tracked by Wall St. Rank hold CRL as of Q3 2020.

  • First Allied Advisory Services held 1,467 shares of Charles River Laboratories worth $332K as of Q3 2020.
  • First Allied Advisory Services bought 39 Charles River Laboratories shares in Q3 2020, an estimated $8.09K.
  • Charles River Laboratories made up 0.01% of First Allied Advisory Services's portfolio in Q3 2020, its #860 holding.
  • First Allied Advisory Services first reported a position in Charles River Laboratories in Q4 2019 and has held it in 3 quarters since.
  • 491 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2020.

Based on First Allied Advisory Services's 13F filing for Q3 2020, filed 13 Nov 2020.